The Valley Desk

NCT04362813 · Interventional trial

Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia

Overall registry status Completed

Phase 3

Conditions Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov